From rapa nui to rapamycin : targeting PI3K/Akt/mTOR for cancer therapyGEORGAKIS, Georgios V; YOUNES, Anas.Expert review of anticancer therapy. 2006, Vol 6, Num 1, pp 131-140, issn 1473-7140, 10 p.Article

Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders: A short reviewYOUNES, Anas; AGGARWALL, Bharat B.Cancer. 2003, Vol 98, Num 3, pp 458-467, issn 0008-543X, 10 p.Article

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapyYOUNES, Anas; KADIN, Marshall E.Journal of clinical oncology. 2003, Vol 21, Num 18, pp 3526-3534, issn 0732-183X, 9 p.Article

CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (APO-21) in haematological malignanciesFIUMARA, Paolo; YOUNES, Anas.British journal of haematology. 2001, Vol 113, Num 2, pp 265-274, issn 0007-1048Article

Novel treatment strategies for patients with relapsed classical Hodgkin lymphomaJONA, Adam; YOUNES, Anas.Blood reviews. 2010, Vol 24, Num 6, pp 233-238, issn 0268-960X, 6 p.Article

Monoclonal antibodies in the treatment of non-Hodgkin's lymphomaFANALE, Michelle A; YOUNES, Anas.Drugs (Basel). 2007, Vol 67, Num 3, pp 333-350, issn 0012-6667, 18 p.Article

From empiric to mechanism-based therapy for peripheral T cell lymphoma : Peripheral T cell lymphomaINTLEKOFER, Andrew M; YOUNES, Anas.International journal of hematology. 2014, Vol 99, Num 3, pp 249-262, issn 0925-5710, 14 p.Article

New treatment strategies for aggressive lymphomaYOUNES, Anas.Seminars in oncology. 2004, Vol 31, Num 6, pp 10-13, issn 0093-7754, 4 p., SUP15Article

Brentuximab Vedotin (SGN-35) : Antibody Conjugates: The Futures Is NowKATZ, Jessica; JANIK, John E; YOUNES, Anas et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6428-6436, issn 1078-0432, 9 p.Article

Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and ManagementABU-ALFA, Ali K; YOUNES, Anas.American journal of kidney diseases. 2010, Vol 55, Num 5, issn 0272-6386, S1-S13, SUP3Article

The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9GEORGAKIS, Georgios V; YANG LI; YOUNES, Anas et al.British journal of haematology. 2006, Vol 135, Num 1, pp 68-71, issn 0007-1048, 4 p.Article

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensusCAIRO, Mitchell S; COIFFIER, Bertrand; REITER, Alfred et al.British journal of haematology. 2010, Vol 149, Num 4, pp 578-586, issn 0007-1048, 9 p.Article

Estrogen receptor β is expressed in human colorectal adenocarcinomaWITTE, Deborah; CHIRALA, Minni; YOUNES, Anas et al.Human pathology. 2001, Vol 32, Num 9, pp 940-944, issn 0046-8177Article

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome : An Evidence-Based ReviewCOIFFIER, Bertrand; ALTMAN, Arnold; PUI, Ching-Hon et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2767-2778, issn 0732-183X, 12 p.Article

Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinomaYOUNES, Mamoun; GEORGAKIS, Georgios V; RAHMANI, Mahdis et al.European journal of cancer (1990). 2006, Vol 42, Num 4, pp 542-547, issn 0959-8049, 6 p.Article

Epidermal growth factor receptor expression in follicular dendritic cells: A shared feature of follicular dendritic cell sarcoma and Castleman's diseaseXIAOPING SUN; CHANG, Kong-Chao; ABRUZZO, Lynne V et al.Human pathology. 2003, Vol 34, Num 9, pp 835-840, issn 0046-8177, 6 p.Article

Decreased Sensitivity of 17p-Deleted Chronic Lymphocytic Leukemia Cells to a Small Molecule BCL-2 Antagonist ABT-737KOJIMA, Kensuke; DUVVURI, Seshagiri; RUVOLO, Vivian et al.Cancer. 2012, Vol 118, Num 4, pp 1023-1031, issn 0008-543X, 9 p.Article

Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphomaYOUNES, Anas; FAYAD, Luis; ROMAGUERA, Jorge et al.European journal of cancer (1990). 2006, Vol 42, Num 17, pp 2976-2981, issn 0959-8049, 6 p.Article

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo^®) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomasHAGEMEISTER, Fredrick; RODRIGUEZ, Maria Alma; PRO, Barbara et al.British journal of haematology. 2013, Vol 162, Num 5, pp 631-638, issn 0007-1048, 8 p.Article

Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II StudyYOUNES, Anas; SUREDA, Anna; LE CORRE, Christophe et al.Journal of clinical oncology. 2012, Vol 30, Num 18, pp 2197-2203, issn 0732-183X, 7 p.Article

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphomaYOUNES, Anas; OKI, Yasuhiro; HAGEMEISTER, Fredrick et al.Blood. 2012, Vol 119, Num 18, pp 4123-4128, issn 0006-4971, 6 p.Article

Phase I Multidose-Escalation Study of the Anti-CD 19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-Cell LymphomaYOUNES, Anas; KIM, Stella; LAMBERT, John M et al.Journal of clinical oncology. 2012, Vol 30, Num 22, pp 2776-2782, issn 0732-183X, 7 p.Article

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive LymphomasYOUNES, Anas; BARTLETT, Nancy L; LEONARD, John P et al.The New England journal of medicine. 2010, Vol 363, Num 19, pp 1812-1821, issn 0028-4793, 10 p.Article

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell LymphomaWANG, Michael; OKI, Yasuhiro; SAMUELS, Barry I et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5213-5218, issn 0732-183X, 6 p.Article

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsLUQMAN, Mohammad; KLABUNDE, Sha; LEA AUKERMAN, Sharon et al.Blood. 2008, Vol 112, Num 3, pp 711-720, issn 0006-4971, 10 p.Article